H.R. 1532, known as the "Scientific EXPERT Act of 2025," aims to amend the Federal Food, Drug, and Cosmetic Act to facilitate drug development for rare diseases. It establishes a process for holding science-focused meetings led by external experts, involving medical professionals, drug...
Simple Explanation
The "Scientific EXPERT Act of 2025" is a new rule that helps doctors and scientists have meetings to talk about making new medicines for rare sicknesses, making sure they work safely, and getting them ready faster for people who need them.